{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:21:06Z","timestamp":1790716866093,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.carrev.2023.04.014","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T03:41:15Z","timestamp":1681702875000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registry"],"prefix":"10.1016","volume":"55","author":[{"given":"Luca","family":"Testa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Criscione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Popolo Rubbio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Squillace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Ielasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Tespili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedy","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.carrev.2023.04.014_bb0005","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.1532\/hsf.2243","article-title":"A comparative study of TAVR versus SAVR in moderate and high-risk surgical patients: hospital outcome and midterm results","volume":"22","author":"Abdelgawad","year":"2019","journal-title":"Heart Surg Forum"},{"issue":"17","key":"10.1016\/j.carrev.2023.04.014_bb0010","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.carrev.2023.04.014_bb0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jamacardio.2016.2257","article-title":"Outcomes in the randomized CoreValve US pivotal high risk trial in patients with a Society of Thoracic Surgeons risk score of 7% or less","volume":"1","author":"Reardon","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"14","key":"10.1016\/j.carrev.2023.04.014_bb0020","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.carrev.2023.04.014_bb0025","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"10034","key":"10.1016\/j.carrev.2023.04.014_bb0030","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0140-6736(16)30073-3","article-title":"Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis","volume":"387","author":"Thourani","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.carrev.2023.04.014_bb0035","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2017.06.045","article-title":"Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the international FORWARD study","volume":"70","author":"Grube","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.carrev.2023.04.014_bb0040","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.carrev.2023.04.014_bb0045","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.carrev.2023.04.014_bb0050","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-18-00460","article-title":"One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVR trial","volume":"14","author":"Serruys","year":"2018","journal-title":"EuroIntervention"},{"issue":"20","key":"10.1016\/j.carrev.2023.04.014_bb0055","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis","volume":"65","author":"Thyregod","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2023.04.014_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2217\/fca-2020-0020","article-title":"Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosis","volume":"17","author":"Sharma","year":"2021","journal-title":"Future Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2023.04.014_bb0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4244\/EIJ-D-19-00413","article-title":"First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study","volume":"16","author":"Sharma","year":"2020","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.carrev.2023.04.014_bb0070","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.carrev.2023.04.014_bb0075","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.carrev.2023.04.014_bb0080","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis \u2014 from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.carrev.2023.04.014_bb0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.athoracsur.2015.05.021","article-title":"Outcomes in nonagenarians undergoing transcatheter aortic valve replacement in the PARTNER-I trial","volume":"100","author":"Thourani","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.carrev.2023.04.014_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/17434440.2017.1282819","article-title":"Pathophysiology, incidence and predictors of conduction disturbances during transcatheter aortic valve implantation","volume":"14","author":"Barbanti","year":"2017","journal-title":"Expert Rev Med Devices"},{"issue":"14","key":"10.1016\/j.carrev.2023.04.014_bb0095","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa2204961","article-title":"PROTECTED TAVR investigators. Cerebral embolic protection during transcatheter aortic-valve replacement","volume":"387","author":"Kapadia","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2023.04.014_bb0100","first-page":"677","article-title":"Transcatheter aortic valve implantation with Allegra: procedural and mid-term outcomes according to experience phase in a high-volume center","volume":"70","author":"Corcione","year":"2022","journal-title":"Minerva Cardiol Angiol"},{"key":"10.1016\/j.carrev.2023.04.014_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.817705","article-title":"Transcatheter aortic valve implantation for severe bicuspid aortic stenosis - 2 years follow up experience from India","volume":"9","author":"Kumar","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.carrev.2023.04.014_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2021.12.049","article-title":"Myval versus alternative balloon- and self-expandable transcatheter heart valves: a central core lab analysis of conduction disturbances","volume":"351","author":"Santos-Martinez","year":"2022","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2023.04.014_bb0115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00059-021-05069-4","article-title":"First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study","volume":"47","author":"Aky\u00fcz","year":"2022","journal-title":"Herz"},{"issue":"1","key":"10.1016\/j.carrev.2023.04.014_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5334\/gh.959","article-title":"Quantitative angiographic assessment of aortic regurgitation after transcatheter aortic valve implantation among three balloon-expandable valves","volume":"16","author":"Kawashima","year":"2021","journal-title":"Glob Heart"},{"key":"10.1016\/j.carrev.2023.04.014_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ahj.2020.11.001","article-title":"Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial","volume":"232","author":"Kawashima","year":"2021","journal-title":"Am Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923001550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838923001550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:26:44Z","timestamp":1761560804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838923001550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":25,"alternative-id":["S1553838923001550"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2023.04.014","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registry","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2023.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}